Recursion Pharmaceuticals, Inc. (RXRX)

3.635 +0.10 (+2.68%) USD  |  NASDAQ  |  Mar 04, 16:00
3.60 -0.04 (-0.96%) After-Hours: 20:00
More

Recursion Pharmaceuticals Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for RXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Intellia Therapeutics, Inc. Upgrade
Hims & Hers Health, Inc. Upgrade
Novavax, Inc. Upgrade
Geron Corp. Upgrade
XOMA Royalty Corp. Upgrade